Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2017 2
2018 3
2019 1
2020 2
2021 2
2022 2
2023 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer.
Powles T, Valderrama BP, Gupta S, Bedke J, Kikuchi E, Hoffman-Censits J, Iyer G, Vulsteke C, Park SH, Shin SJ, Castellano D, Fornarini G, Li JR, Gümüş M, Mar N, Loriot Y, Fléchon A, Duran I, Drakaki A, Narayanan S, Yu X, Gorla S, Homet Moreno B, van der Heijden MS; EV-302 Trial Investigators. Powles T, et al. N Engl J Med. 2024 Mar 7;390(10):875-888. doi: 10.1056/NEJMoa2312117. N Engl J Med. 2024. PMID: 38446675 Clinical Trial.
Durvalumab in urothelial cancers.
Lavaud P, Hamilou Z, Loriot Y, Massard C. Lavaud P, et al. Among authors: hamilou z. Expert Rev Anticancer Ther. 2018 Apr;18(4):311-318. doi: 10.1080/14737140.2018.1443812. Epub 2018 Mar 5. Expert Rev Anticancer Ther. 2018. PMID: 29486607 Review.
Atezolizumab in urothelial bladder carcinoma.
Hamilou Z, Lavaud P, Loriot Y. Hamilou Z, et al. Future Oncol. 2018 Feb;14(4):331-341. doi: 10.2217/fon-2017-0433. Epub 2017 Nov 14. Future Oncol. 2018. PMID: 29135284 Review.
Treatment of hormone-naïve metastatic prostate cancer.
Hamilou Z, Saad F, Fizazi K. Hamilou Z, et al. Curr Opin Support Palliat Care. 2018 Sep;12(3):334-338. doi: 10.1097/SPC.0000000000000359. Curr Opin Support Palliat Care. 2018. PMID: 30015691 Review.
Gut microbiome predicts gastrointestinal toxicity outcomes from chemoradiation therapy in patients with head and neck squamous cell carcinoma.
Hes C, Desilets A, Tonneau M, El Ouarzadi O, De Figueiredo Sousa M, Bahig H, Filion É, Nguyen-Tan PF, Christopoulos A, Benlaïfaoui M, Derosa L, Alves Costa Silva C, Ponce M, Malo J, Belkad W, Charpentier D, Aubin F, Hamilou Z, Jamal R, Messaoudene M, Soulières D, Routy B. Hes C, et al. Among authors: hamilou z. Oral Oncol. 2024 Jan;148:106623. doi: 10.1016/j.oraloncology.2023.106623. Epub 2023 Nov 24. Oral Oncol. 2024. PMID: 38006691
14 results